Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients. [electronic resource]
Producer: 20150413Description: 1101-6 p. digitalISSN:- 1592-8721
- Adult
- Agammaglobulinemia -- drug therapy
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Drug Substitution
- Female
- Humans
- Immunoglobulin G -- blood
- Immunoglobulins -- administration & dosage
- Immunoglobulins, Intravenous -- administration & dosage
- Immunologic Factors -- adverse effects
- Infections -- etiology
- Infusions, Subcutaneous
- Lymphoproliferative Disorders -- complications
- Male
- Middle Aged
- Retrospective Studies
- Rituximab
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.